This post was originally published on this site
MARKETWATCH FRONT PAGE
A mix of legacy drugmakers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel coronavirus. See full story.
Stock market won’t hit coronavirus lows until these 3 criteria are met, says Goldman Sachs
Stock-market analysts at Goldman Sachs believe the S&P 500 will end this year more than 19% above current levels, but warned investors in a note this weekend that there will be short-term pain the markets in coming weeks. See full story.
Dow gains more than 200 points despite Boeing decline as market focuses on efforts to slow coronavirus spread
Stocks rise Monday, as the number of coronavirus cases and deaths continues to rise and investors brace for data in the week ahead expected to underline the economic toll of the pandemic. See full story.
I’m retired and claim Social Security — do I still get the $1,200 stimulus check?
Congress is expected to pass a bill giving Americans hurt by the coronavirus crisis financial relief. See full story.
When you lose your sense of smell and taste, should you suspect coronavirus?
Anecdotal evidence describes a high incidence in COVID-19 patients. See full story.
MARKETWATCH PERSONAL FINANCE
Before the coronavirus outbreak worsened in the U.S., every region in the country saw gains in contract signings for home purchases. See full story.
